Medullary Thyroid Cancer-Pipeline Insights, 2016


#515472

60pages

DelveInsight

$ 1250

In Stock

SUMMARY
DelveInsights, Medullary Thyroid Cancer-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Medullary Thyroid Cancer. The DelveInsightsReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsights Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Medullary Thyroid Cancer. DelveInsights Report also assesses the Medullary Thyroid Cancer therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.
Scope